BHEIX
Price
$29.30
Change
-$0.05 (-0.17%)
Updated
Nov 13 closing price
MENRX
Price
$10.13
Change
+$0.03 (+0.30%)
Updated
Nov 13 closing price
Ad is loading...

BHEIX vs MENRX

Header iconBHEIX vs MENRX Comparison
Open Charts BHEIX vs MENRXBanner chart's image
BlackRock High Equity Income K
Price$29.30
Change-$0.05 (-0.17%)
VolumeN/A
CapitalizationN/A
Madison Covered Call & Equity Income R6
Price$10.13
Change+$0.03 (+0.30%)
VolumeN/A
CapitalizationN/A
BHEIX vs MENRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BHEIX vs. MENRX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHEIX is a StrongBuy and MENRX is a StrongSell.

FUNDAMENTALS
Fundamentals
BHEIX has more cash in the bank: 2B vs. MENRX (250M). MENRX pays higher dividends than BHEIX: MENRX (7.54) vs BHEIX (6.55). BHEIX was incepted earlier than MENRX: BHEIX (5 years) vs MENRX (12 years). BHEIX is a more actively managed with annual turnover of: 126.00 vs. MENRX (102.00). MENRX has a lower initial minimum investment than BHEIX: MENRX (500000) vs BHEIX (5000000). BHEIX annual gain was more profitable for investors over the last year : 21.32 vs. MENRX (10.45).
BHEIXMENRXBHEIX / MENRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years12 years-
Gain YTD11.9744.863246%
Front LoadN/AN/A-
Min. Initial Investment50000005000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2B250M799%
Annual Yield % from dividends6.557.5487%
Returns for 1 year21.3210.45204%
Returns for 3 years21.1318.01117%
Returns for 5 yearsN/A61.64-
Returns for 10 yearsN/A69.62-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOOG183.321.35
+0.74%
Alphabet
DSGX115.26-0.40
-0.35%
Descartes Systems Group
ESPR2.43-0.08
-3.37%
Esperion Therapeutics
FOR29.71-1.29
-4.16%
Forestar Group
BWAY9.70-1.10
-10.19%
BrainsWay Ltd